David Abrams Abrams Capital Management
David Abrams is the founder of Abrams Capital Management, a Boston-based firm with a flexible value-oriented mandate. A former Baupost Group investor, he is known for concentrated positions and a willingness to hold cash or unconventional securities when public equities are unattractive. Abrams Capital’s filings are followed for high-conviction ideas across equities and special situations.
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$62.6M |
| 2 |
Meta Platforms (Facebook)
META
|
+$40.6M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$36.5M |
| 4 |
Willis Towers Watson
WTW
|
+$22.6M |
| 5 |
U-Haul Holding Co
UHAL
|
+$8.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 56.05% |
| 2 | Communication Services | 19.15% |
| 3 | Energy | 8.76% |
| 4 | Industrials | 7.97% |
| 5 | Financials | 6.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Lithia Motors
LAD
$8.15B
| $719M | 22.47% |
2,391,188
| – | – |
|
2
Asbury Automotive
ABG
$3.86B
| $497M | 15.53% |
2,108,540
| – | – |
|
|
3
Alphabet (Google) Class A
GOOGL
$4.22T
| $312M | 9.74% |
2,067,195
-255,145
| -11% | -$36.5M |
|
|
4
Meta Platforms (Facebook)
META
$1.4T
| $301M | 9.41% |
620,547
-91,003
| -13% | -$40.6M |
|
5
Energy Transfer Partners
ET
$73B
| $281M | 8.76% |
17,834,322
| – | – |
|
|
6
U-Haul Holding Co Series N
UHAL.B
$12.3B
| $236M | 7.38% |
3,545,220
-118,023
| -3% | -$7.6M |
|
7
Coupang
CPNG
$29.6B
| $232M | 7.23% |
13,017,964
| – | – |
|
|
SGI
8
Somnigroup International
SGI
$13.6B
| $205M | 6.39% |
3,600,000
| – | – |
|
|
9
Willis Towers Watson
WTW
$31.8B
| $198M | 6.19% |
720,779
-86,057
| -11% | -$22.6M |
|
10
Camping World
CWH
$676M
| $142M | 4.44% |
5,108,808
| – | – |
|
|
CTLP
11
DELISTED
Cantaloupe
CTLP
| $46.2M | 1.44% |
7,180,000
| – | – |
|
|
12
U-Haul Holding Co
UHAL
$13.9B
| $18.7M | 0.58% |
277,011
-130,016
| -32% | -$8.59M |
|
13
Nuvation Bio
NUVB
$2.43B
| $13.9M | 0.43% |
3,811,513
| – | – |
|
|
14
Teva Pharmaceuticals
TEVA
$43.5B
| – | – |
-5,996,836
| Closed | -$62.6M |
|
15
USCB Financial Holdings
USCB
$415M
| – | – |
-149,786
| Closed | -$1.83M |
|
Similar funds
David Abrams's Q1 2024 Portfolio in Review
As of Q1 2024, David Abrams held 15 positions worth $3.2B, down 0.48% from $3.22B the previous quarter. Its ten largest holdings account for 98% of the portfolio.
David Abrams withdrew a net $180M in Q1 2024, closing 2 positions and reducing 5 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $62.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 56% of assets, up from 56% a quarter earlier, followed by Communication Services and Energy.
- David Abrams's biggest Q1 2024 reduction was Meta Platforms (Facebook), cutting an estimated $40.6M.
- David Abrams fully exited Teva Pharmaceuticals in Q1 2024, selling an estimated $62.6M.
- David Abrams's ten largest holdings make up 98% of its $3.2B portfolio in Q1 2024.
- David Abrams opened 0 new positions and closed 2 in Q1 2024.
- David Abrams's portfolio value fell 0.48% quarter-over-quarter to $3.2B.
Based on Abrams Capital Management's 13F filing for Q1 2024, filed 14 May 2024.